The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens

por Burakoff, SJ, Finberg, R, Glimcher, L, Lemonnier, F, Benacerraf, B, Cantor, H
Publicado 1978

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide

por Gross, D. A., Leborgne, C., Chappert, P., Masurier, C., Leboeuf, M., Monteilhet, V., Boutin, S., Lemonnier, F. A., Davoust, J., Kichler, A.
Publicado 2019

In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse

por Scardino, A, Correale, P, Firat, H, Pellegrini, M, Kosmatopoulos, K, Opolon, P, Alves, P, Zurbriggen, R, Glück, R, Lemonnier, F A, Francini, G, Cusi, M G
Publicado 2003

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides

por Bar-Haim, E, Paz, A, Machlenkin, A, Hazzan, D, Tirosh, B, Carmon, L, Brenner, B, Vadai, E, Mor, O, Stein, A, Lemonnier, F A, Tzehoval, E, Eisenbach, L
Publicado 2004

PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS ST...

por Borchmann, P., Vandenberghe, P., Urbano, A., Haioun, C., Lemonnier, F., Griškevicius, L., Maury, S., Holtkamp, S., Friedrichs, B., Zadoyan, G., Hanssens, L., Brillant, C., Bethke, U., Assenmacher, M., Bürger, I., Philippe, B., Overstijns, T., Jäger, U., Kersten, M. J.
Publicado 2022